Tattoo enthusiasts in New York are being advised to avoid certain Sacred Tattoo Ink products after the U.S. Food and Drug Administration (FDA) issued a warning about contamination with potentially harmful bacteria. Routine testing of the inks revealed the presence of Pseudomonas aeruginosa, a bacterium known to cause serious skin infections when injected into the body.
The affected ink products are Sacred Tattoo Ink Raven Black (Lot#: RB0624, Best Before June 28, 2027) and Sacred Tattoo Ink Sunny Daze (Lot#: SD1124, Best Before Nov. 1, 2027). These inks were found to be contaminated, prompting the FDA to urge consumers, tattoo artists, and retailers to take immediate action. The FDA’s warning is focused on preventing the further use of these contaminated products and ensuring they are removed from circulation.
“Anytime the skin barrier is broken, there’s a risk of infection,” the FDA stated. “Contaminated tattoo inks increase that risk significantly, and symptoms may not be immediately recognized.” Early signs of infection include rashes, red papules, and lesions at the site of the tattoo. In some cases, these infections can lead to permanent scarring or require medical treatment. The FDA also expressed concern that the early symptoms of infection may be mistaken for allergic reactions, complicating timely diagnosis and treatment.
Tattooing remains a popular and thriving industry across New York, with countless independent studios and parlors offering services. In light of this, the FDA is advising individuals planning to get tattooed to inquire about the inks their artists use and ensure that neither of the recalled Sacred Tattoo Ink products are in use.
Tattoo shops and retailers are being instructed to stop using and selling the affected ink products immediately. The FDA has stated that it will continue to monitor the situation and collaborate with manufacturers to remove the contaminated products from the market.
Consumers who may have already used these inks are encouraged to seek medical attention if they experience any concerning symptoms. The FDA is also working closely with tattoo artists and retailers to ensure that any remaining contaminated stock is withdrawn from the market and that public safety is prioritized.
Related topics: